Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 2446 AL 2460

Icariin ameliorate Alzheimer's disease by influencing SIRT1 and inhibiting Aβ cascade pathogenesis

Chuang Y, Van I, Zhao Y, Xu Y.

J Chem Neuroanat. 2021 Nov;117:102014. doi: 10.1016/j.jchemneu.2021.102014. Epub 2021 Aug 15.

Microbiota-gut-brain axis and Alzheimer's disease: Implications of the blood-brain barrier as an intervention target

Liu S, Gao J, Liu K, Zhang HL.

Mech Ageing Dev. 2021 Oct;199:111560. doi: 10.1016/j.mad.2021.111560. Epub 2021 Aug 16.

Masitinib for the treatment of Alzheimer's disease

Ettcheto M, Cano A, Sanchez-López E, Verdaguer E, Folch J, Auladell C, Camins A.

Neurodegener Dis Manag. 2021 Aug;11(4):263-276. doi: 10.2217/nmt-2021-0019. Epub 2021 Aug 20.

Prescription Patterns of Antidementia and Psychotropic Drugs in People Living With Dementia: Findings From the Clinical Pathway Study of Alzheimer's Disease in China

Zhang Y, Luo H, Wong GHY, Zhao M, Lv X, Lum TYS, Chui CSL, Yu X, Wong ICK, Wang H.

J Am Med Dir Assoc. 2022 Jun;23(6):1073-1079.e3. doi: 10.1016/j.jamda.2021.07.017. Epub 2021 Aug 18.

The pleiotropic roles of autophagy in Alzheimer's disease: From pathophysiology to therapy

Festa BP, Barbosa AD, Rob M, Rubinsztein DC.

Curr Opin Pharmacol. 2021 Oct;60:149-157. doi: 10.1016/j.coph.2021.07.011. Epub 2021 Aug 19.

Aducanumab and the Medicalization (Still) of Alzheimer's Disease: A Challenge to Measure and Act On What Matters

Fick DM.

J Gerontol Nurs. 2021 Sep;47(9):2-4. doi: 10.3928/00989134-20210806-01. Epub 2021 Sep 1.

Novel strategies for the fight of Alzheimer's disease targeting amyloid-β protein

Xie Y, Wang Y, Jiang S, Xiang X, Wang J, Ning L.

J Drug Target. 2022 Mar;30(3):259-268. doi: 10.1080/1061186X.2021.1973482. Epub 2021 Sep 3.

Marine-Derived Compounds with Anti-Alzheimer's Disease Activities

Hafez Ghoran S, Kijjoa A.

Mar Drugs. 2021 Jul 24;19(8):410. doi: 10.3390/md19080410.

Unravelling the potential neuroprotective facets of erythropoietin for the treatment of Alzheimer's disease

Kaur D, Behl T, Sehgal A, Singh S, Sharma N, Badavath VN, Ul Hassan SS, Hasan MM, Bhatia S, Al-Harassi A, Khan H, Bungau S.

Metab Brain Dis. 2022 Jan;37(1):1-16. doi: 10.1007/s11011-021-00820-6. Epub 2021 Aug 26.

cAMP Compartmentalization in Cerebrovascular Endothelial Cells: New Therapeutic Opportunities in Alzheimer's Disease

Viña D, Seoane N, Vasquez EC, Campos-Toimil M.

Cells. 2021 Jul 31;10(8):1951. doi: 10.3390/cells10081951.

Deconstructing Alzheimer's Disease: How to Bridge the Gap between Experimental Models and the Human Pathology?

Vignon A, Salvador-Prince L, Lehmann S, Perrier V, Torrent J.

Int J Mol Sci. 2021 Aug 16;22(16):8769. doi: 10.3390/ijms22168769.

Decrypting the potential role of α-lipoic acid in Alzheimer's disease

Kaur D, Behl T, Sehgal A, Singh S, Sharma N, Chigurupati S, Alhowail A, Abdeen A, Ibrahim SF, Vargas-De-La-Cruz C, Sachdeva M, Bhatia S, Al-Harrasi A, Bungau S.

Life Sci. 2021 Nov 1;284:119899. doi: 10.1016/j.lfs.2021.119899. Epub 2021 Aug 25.

A Review of Techniques for Biodelivery of Nerve Growth Factor (NGF) to the Brain in Relation to Alzheimer's Disease

Mitra S, Gera R, Linderoth B, Lind G, Wahlberg L, Almqvist P, Behbahani H, Eriksdotter M.

Adv Exp Med Biol. 2021;1331:167-191. doi: 10.1007/978-3-030-74046-7_11.

NGF Released from Blood Cells or Collagen Hydrogels as a Therapeutic Target in Alzheimer's Disease?

Humpel C.

Adv Exp Med Biol. 2021;1331:193-202. doi: 10.1007/978-3-030-74046-7_12.

Current druggable targets for therapeutic control of Alzheimer's disease

Gupta GL, Samant NP.

Contemp Clin Trials. 2021 Oct;109:106549. doi: 10.1016/j.cct.2021.106549. Epub 2021 Aug 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias